Curriculum Vitae

PROF. DR. AZAD HASSAN BIN ABDUL RAZACK

Honorary Professor
  • Department of Surgery
    Faculty of Medicine
  • azad
  • +603-79492070

AREAS OF EXPERTISE


  • UROLOGY
    Neuro-urology
  • UROLOGY
  • CLINICAL MEDICINE

ACADEMIC QUALIFICATION


  • FRCSed(1991) (UK), (Urology)
    Royal College of Surgeons, Edinburgh
  • MBBS(1986) (UM), (Medicine and Surgery)
    Universiti Malaya (UM)

ADMINISTRATIVE DUTIES


  • Head of Department
    01 Aug 2018 - 30 Jan 2019 (Department of Surgery, Faculty of Medicine)
  • Chairman
    14 Mar 2018 - 30 Jan 2019 (University Malaya)
  • Head of Department
    01 Feb 2017 - 31 Jul 2018 (Department of Surgery, Faculty of Medicine)
  • Deputy Dean of Development
    01 Aug 2014 - 31 Aug 2016 (Dean's Office, Faculty of Medicine)
  • Deputy Dean of Development
    01 Jul 2014 - 31 Jul 2014 (Dean's Office, Faculty of Medicine)
  • Deputy Dean of Development
    01 Apr 2013 - 30 Jun 2014 (Dean's Office, Faculty of Medicine)
  • Head of Department
    01 Sep 2009 - 01 May 2011 (Department of Surgery, Faculty of Medicine)
  • Head of Department
    01 Sep 2007 - 31 Aug 2009 (Department of Surgery, Faculty of Medicine)
  • Head of Department
    01 Sep 2006 - 31 Aug 2007 (Department of Surgery, Faculty of Medicine)

AWARD AND STEWARDSHIP


  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2016 (University)
  • KHIDMAT SETIA 20 AWARD
    University of Malaya, 2013 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2009 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2007 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2006 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2003 (University)

PUBLICATIONS


Article in Journal
  1. Conti DV, Darst DF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, ......, Razack A, Lim J, Teo SH, et al (2021) Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 53(1):65-75. doi: 10.1038/s41588-020-00748-0
  2. Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Eeles RA, Kote-Jarai Z, Muir K, Lophatananon A, UKGPCS collaborators; Schleutker J, Pashayan N, Batra J, APCB BioResource (Australian Prostate Cancer BioResource); Gr nberg H, Walsh EI, Turner EL, Lane A, Martin RM, Neal DE, Donovan JL, Hamdy FC, Nordestgaard BG, Tangen CM, MacInnis RJ, Wolk A, Albanes D, Haiman CA, Travis RC, Stanford JL, Mucci LA, West CML, Nielsen SF, Kibel AS, Wiklund F, Cussenot O, Berndt SI, Koutros S, S rensen KD, Cybulski C, Grindedal EM, Park JY, Ingles SA, Maier C, Hamilton RJ, Rosenstein BS, Vega A, IMPACT Study Steering Committee and Collaborators; Kogevinas M, Penney KL, Teixeira MR, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, Razack A, Newcomb LF, Canary PASS Investigators; Gamulin M, Usmani N, Claessens F, Gago-Dominguez M, Townsend PA, Roobol MJ, Zheng W, Profile Study Steering Committee; Mills IG, Andreassen OA, Dale AM, Seibert TM, PRACTICAL Consortium (2021). Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer. Prostate Cancer Prostatic Dis. doi:10.1038/s41391-020-00311-2
  3. Brand o, A.; Paulo, P.; Maia, S.; Pinheiro, M.; Peixoto, A.; Cardoso, M.; Silva, M.P.; Santos, C.; Eeles, R.A.; Kote-Jarai, Z.; Muir, K.; UKGPCS Collaborators; Schleutker, J.; Wang, Y.; Pashayan, N.; Batra, J.; APCB BioResource; Gr nberg, H.; Neal, D.E.; Nordestgaard, B.G.; Tangen, C.M.; Southey, M.C.; Wolk, A.; Albanes, D.; Haiman, C.A.; Travis, R.C.; Stanford, J.L.; Mucci, L.A.; West, C.M.L.; Nielsen, S.F.; Kibel, A.S.; Cussenot, O.; Berndt, S.I.; Koutros, S.; S rensen, K.D.; Cybulski, C.; Grindedal, E.M.; Park, J.Y.; Ingles, S.A.; Maier, C.; Hamilton, R.J.; Rosenstein, B.S.; Vega, A.; The IMPACT Study Steering Committee and Collaborators; Kogevinas, M.; Wiklund, F.; Penney, K.L.; Brenner, H.; John, E.M.; Kaneva, R.; Logothetis, C.J.; Neuhausen, S.L.; Ruyck, K.D.; Razack, A.; Newcomb, L.F.; Canary PASS Investigators; Lessel, D.; Usmani, N.; Claessens, F.; Gago-Dominguez, M.; Townsend, P.A.; Roobol, M.J.; The Profile Study Steering Committee; The PRACTICAL Consortium; Teixeira, M.R. (2020) The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor. Cancers. 12(11): 3254.
  4. Uemura H et al United in Fight against prOstate cancer (UFO) registry; first results from a large, multi-centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia
  5. Yii, R., Lim, J., Sothilingam, S., Yeoh, W. S., Fadzli, A. N., Ong, T. A., Kuppusamy, S., & Abdul Razack, A. H. (2020). Predictive factors of prostate cancer diagnosis with PSA 4.0-10.0 ng/ml in a multi-ethnic Asian population, Malaysia. Asian journal of surgery, 43(1), 87 94. https://doi.org/10.1016/j.asjsur.2019.02.014
  6. Mat S, Razack AH et al Factors determining the increased risk of falls in individuals with knee pain in Malaysian Elders Longitudinal Research (MELoR)
  7. Saad M et al Management of advanced prostate cancer in a middle-income country: real-world consideration of Advanced Prostate Cancer Consensus Conference 2017
  8. Tan JSJ, Ong KC, Ong DBL, Wu YS, Razack A, Kuppusamy S, Lim J, Rhodes A (2019) Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer. Malaysian J Pathol. 41 (3): 243 - 251
  9. Dadaev, T., Saunders, E. J., Newcombe, P. J., Anokian, E., Leongamornlert, D. A., Brook, M. N., Cieza-Borrella, C., Mijuskovic, M., Wakerell, S., Olama, A., Schumacher, F. R., Berndt, S. I., Benlloch, S., Ahmed, M., Goh, C., Sheng, X., Zhang, Z., Muir, K., Govindasami, K., Lophatananon, A., Kote-Jarai, Z. (2018). Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nature communications, 9(1), 2256. https://doi.org/10.1038/s41467-018-04109-8
  10. Kuppusamy S, Quek KF, Rajandram R, Razack AHA and Dublin N (2018). Revisiting prostate specific antigen density (PSAD): a prospective analysis in predicting the histology of prostate biopsy. International Journal of Clinical and Experimental Medicine (Accepted)
  11. Lim, J., Rampal, S., Razack, A., Malek, R., Sundram, M., Nasuha, N. A., Ooi, C. C., Ong, T. A., & Sothilingam, S. (2018). A Novel Calculator for Estimating Prostate Volume in Daily Urology Services. Urology, 118, 145 151. https://doi.org/10.1016/j.urology.2018.02.055
  12. Ng, K. L., Yap, N. Y., Rajandram, R., Small, D., Pailoor, J., Ong, T. A., Razack, A. H., Wood, S. T., Morais, C., & Gobe, G. C. (2018). Nuclear factor-kappa B subunits and their prognostic cancer-specific survival value in renal cell carcinoma patients. Pathology, 50(5), 511 518. https://doi.org/10.1016/j.pathol.2018.03.003
  13. Schumacher, F. R., Al Olama, A. A., Berndt, S. I., Benlloch, S., Ahmed, M., Saunders, E. J., Dadaev, T., Leongamornlert, D., Anokian, E., Cieza-Borrella, C., Goh, C., Brook, M. N., Sheng, X., Fachal, L., Dennis, J., Tyrer, J., Muir, K., Lophatananon, A., Stevens, V. L., Gapstur, S. M., Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium (2018). Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature genetics, 50(7), 928 936. https://doi.org/10.1038/s41588-018-0142-8
  14. Tan JSJ, Ong KC, Ong DBL, Razack A, Lim J, Yunus R, Sundram M, Rhodes A.(2018). Heterogenous expression of ERG oncoprotein in Malaysian men with adenocarcinoma of the prostate. Malays J Pathol. 40(2): 103-110.
  15. Prevathe Poniah, Shamsul Mohd Zain, Azad Hassan Abdul Razack, Shanggar Kuppusamy, Shankar Karuppayah, Hooi Sian Eng, Zahurin Mohamed: Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer. Urologic Oncology 05/2017;, DOI:10.1016/j.urolonc.2017.04.017
  16. Rajandram, R., Yap, N. Y., Ong, T. A., Mun, K. S., Mohamad Wali, H. A., Hasan, M. S., Razack, A., & Ali Mohd, M. (2017). Oral ketamine induced pathological changes of the urinary tract in a rat model. The Malaysian journal of pathology, 39(1), 47 53.
  17. Tan MP, Abdul Razack AH. Newer drugs to treat prostate symptoms are associated with increased risk of falls. Evidence Based Nursing. 2017;20(1):14. doi: 10.1136/eb-2016-102315.
  18. Cheong, A. T., Lee, P. Y., Ng, C. J., Lee, Y. K., Ong, T. A., Abdullah, K. L., & Razack, A. H. A. (2016). Doctors' Approaches to Decision Support in Counseling Patients with Localized Prostate Cancer: An Asian Perspective. Sains Malaysiana, 45(6), 941-947.
  19. Huri HZ, Mat Sanusi ND, Razack AHA, Mark R. (2016). Association of psychological factors, patients' knowledge and management among patients with erectile dysfunction. Patient Preference and Adheranace, 10 (807-823)
  20. Lee, P. Y., Cheong, A. T., Ng, C. J., Lee, Y. K., Abdullah, K. L., Razack, A. H. A., & Ong, T. A. (2016). Supporting patients in making treatment decisions for early prostate cancer: a qualitative study of healthcare professionals views on barriers and challenges in an Asian country. Journal of Men's Health, 12(1), 18-24. https://doi.org/10.31083/jomh.v12i1.21
  21. R Rajandram 1-4, AHA Razack 1-3, KL Ng 1,4, C Morais 4 and GC Gobe 4 (2016). Decreased Expression of Inhibitor of Caspase-Dependent DNase (ICAD) in Renal Cell Carcinoma Tissue Microarray of Human Samples. Journal of Kidney Cancer and VHL. Accepted - in press
  22. Rajandram, R., Ong, T. A., Razack, A. H., MacIver, B., Zeidel, M., & Yu, W. (2016). Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction. American journal of physiology. Renal physiology, 310(9), F885 F894. https://doi.org/10.1152/ajprenal.00483.2015
  23. Lee, Y. K., Lee, P. Y., Cheong, A. T., Ng, C. J., Abdullah, K. L., Ong, T. A., & Razack, A. H. (2015). To Share or Not to Share: Malaysian Healthcare Professionals' Views on Localized Prostate Cancer Treatment Decision Making Roles. PloS one, 10(11), e0142812. https://doi.org/10.1371/journal.pone.0142812
  24. Ong, T. A., Khong, S. Y., Ng, K. L., Ting, J. R., Kamal, N., Yeoh, W. S., Yap, N. Y., & Razack, A. H. (2015). Using the Vibrance Kegel Device With Pelvic Floor Muscle Exercise for Stress Urinary Incontinence: A Randomized Controlled Pilot Study. Urology, 86(3), 487 491. https://doi.org/10.1016/j.urology.2015.06.022
  25. Hasniza Zaman Huri, Tee Lian Choo, Che Zuraini Sulaiman, Raymond Mark, Azad Hassan Abdul Razack Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study. BMJ Open 2014;4:e005381. doi:10.1136/bmjopen-2014- 005381
  26. Jasmine Lim, Nirmala Bhoo-Pathy, Selvalingam Sothilingam, Rohan Malek, Murali Sundram, Badrul Hisham Bahadzor, Teng Aik Ong, Keng Lim Ng, Sivaprakasam Sivalingam, Azad Hassan Abdul Razack Ethnicity Is an Independent Determinant of Age- Specific PSA Level: Findings from a Multiethnic Asian Setting PLOS ONE, August 2014 | Volume 9 | Issue 8 | e104917
  27. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014 Mar;120(3):564-78
  28. Rajandram, R., Yap, N. Y., Pailoor, J., Razack, A. H., Ng, K. L., Ong, T. A., Morais, C., & Gobe, G. C. (2014). Tumour necrosis factor receptor-associated factor-1 (TRAF-1) expression is increased in renal cell carcinoma patient serum but decreased in cancer tissue compared with normal: potential biomarker significance. Pathology, 46(6), 518 522. https://doi.org/10.1097/PAT.0000000000000145
  29. Fatimah Ibrahim, Tee Chee Sian, Kuppusamy Shanggar, Azad Hass an Razack Muslim Prayer Movements as an Alternative Therapy in the Treatment of Erectile Dysfunction: a Preliminary Study Journal of Physical Therapy Science 2013;25(9):1087- 91
  30. Ho,C.C,Seong,P.K., Zainuddin Z.M., Manaf, M.R.A., Parameswaran, M., Razack, A.H.A. 2013. Retrospective study of predictors of bone metastasis in prostate cancer cases 14(5):3289-92
  31. Impact of Applied Progressive Deep Muscle Relaxation Training on Level of Depression, Anxiety and Stress Among Prostate Cancer Patients: A Quasi Experimental Study Isa MR, Moy FM, Razack AH, Zainuddin ZM, Zainal NZ Asian Pacific Journal of Cancer Prevention 2013;14(4):2237-42
  32. Isa M.R., Moy F.M., Razack AH, Zainuddin M.Z., Zainal N.Z.2013. Anxiety Status and its Relationship with General Health Related Quality of Life among Prostate Cancer Patients in Two University Hospitals in Kuala Lumpur, Malaysia. Iranian Journal of Public Health 42 (3):240-8
  33. Jayapalan, J. J., Ng, K. L., Shuib, A. S., Razack, A. H. A. and Hashim, O. H. (2013) Urine of patients with early prostate cancer contains lower levels of light chain fragments of inter-alpha-trypsin inhibitor and saposin B but increased expression of an inter-alpha-trypsin inhibitor heavy chain 4 fragment. Electrophoresis, 34, 1663-1669.
  34. Mohamad-Rodi Isa, Foong Ming Moy, Azad-Hassan Abdul Razack, Zulkifli Md. Zainuddin, Nor-Zuraida Zainal. 2013. Impact of applied progressive deep muscle relaxation training on the health related quality of life among prostate cancer patients A quasi experimental trial.Preventive Medicine. http://dx.doi.org/10.1016/j.ypmed.2013.02.011.In Press, Available online 27 February 2013
  35. Yap, N. Y., Ng, K. L., Ong, T. A., Pailoor, J., Gobe, G. C., Ooi, C. C., Razack, A. H., Dublin, N., Morais, C., & Rajandram, R. (2013). Clinical prognostic factors and survival outcome in renal cell carcinoma patients--a malaysian single centre perspective. Asian Pacific journal of cancer prevention : APJCP, 14(12), 7497 7500. https://doi.org/10.7314/apjcp.2013.14.12.7497
  36. Jayapalan, J. J., Ng, K. L., Razack, A. H. A. and Hashim, O. H. (2012) Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses. Electrophoresis, 33, 1855-1862.
  37. Mohamad, R. I., Moy, F. M., Azad Hassan, A. R., Zulkifli, M. Z., & Nur Zuraida, Z. (2012). General Health Related Quality of Life and its Associated Factors among Prostate Cancer Patients in Two Tertiary Medical Centers in Kuala Lumpur, Malaysia: A Cross-sectional Study. Asian Pacific J Cancer Prev 13(12), 1-4.
  38. Yet Hoi Hong, Norman Dublin, Azad Hassan Razack, Mustafa Ali Mohd, Ruby Husain. Urinary Metabolic Evaluation of Stone Formers - a Malaysian Perspective
  39. Azad HA Razack.2011 Urology in Asia - Malaysia. International Journal of Urology 18(10):684-5
  40. MK Gill, AF Hussain, AHA Razack, MK Seong. Imaging findings of a primary bladder maltoma. British Journal of Radiology 2011
  41. Mirsaed Miri Nargesi1, Patimah Ismail1, Azad Hassan Abdul Razack, Parvin Pasalar, Ali Nazemi, Sima Attaollahi Oshkoor1, Peyman Amini1. Linkage between Prostate Cancer Occurrence and Y-Chromosomal DYS Loci in Malaysian Subjects. Asian Pacific Journal of Cancer Prevention, Vol 12, 2011
  42. NG KL, Sathiyanathan JR, Dublin N, Razack AH, Lee G. 2011 Cyst adenocarcinoma of prostate: A case report JUMMEC 2011 14(1)
  43. Ong T, Yap N, Mun K,Mohamad Ali H, Ali Mohd M, Abdul Razack A, Rajendram R, Hasan M, Poniah P. Damage to the Urinary Tract Induced by Illegal Oral Ketamine in a Rat Model. Urology 2011; 78 (Supplement 3A).
  44. K Shanggar, MZ Zulkifli, AH Razack, N Dublin. Granulomatous Prostatitis: A Reminder to Clinicians. Medical Journal of Malaysia 2010;65(1):21-22
  45. Organ transplants: ethical, social and religious issues in a multi-cultural society. Asia-Pacific Journal of Public Health 2009 Accepted for publication
  46. Yet Hoi Hong, Norman Dublin, Azad Hassan Razack, Mustafa Ali Mohd, Ruby Husain Twenty Four Hour and Spot Urine Metabolic Evaluations: Correlations and Agreements. Urology 2009 Accepted for Publication
  47. Htun TH, Dublin N, Parameswaran M, Razack AH, Chua CB Chronic Myeloid Leukemia Presenting As Priaspm - How Should We Treat? JUMMEC 2008;11(1):27-9
  48. Razack AH Bacillus Calmette-Guerrin and Bladder Cancer Asian J Surgery 2007;30(4):302-9
  49. Razack AH Editorial - Healthy Life Styles JUMMEC 2007:10(1):1
  50. Shanggar K, Muhilan P, Dublin N, Lee EGG, Razack AH An unusual Presentation of a Rare Rhabdomyosarcoma of Urinary Bladder and Prostate. JUMMEC 2007;10(2):57-59
  51. Quek KF, Chua CB, Razack AH, Low WY, Loh CS Construction of the Mandarian Version of the International Prostate Symptom Score Inventory in Assessing Lower Urinary Tract Symptoms in a Malaysian Population International Journal of Urology 2005;12(1):39-45
  52. Quek KF, Razack AH, Chua CB, Low WY, Loh CS Effect of Treating Lower Urinary Tract Symptoms on Anxiety, Depression and Psychiatric Morbidity: a one year study. Int J Urol 2004;11(10):848-55
  53. Tan SP, Bux SI, Kumar G, Razack AH, Chua CB, Lee SH, Liew WF, Tan SY, "Evaluation of live renal donors with three-dimensional contrast enhanced magnetic resonance angiography in comparison to catheter angiography", 2004, Transplant Proc, Vol. 26, pg. 1914-6
  54. Quek KF, Low WY, Razack AH, Loh CS, Chua CB , "Reliability and validity of the Malay version of the International Prostate Symptom Score in the Malaysian population. ", 2002, Vol. 167, no. 3, pg. 1359-62
  55. Quek KF, Loh CS, Low WY, Razack AH , "Quality of Life assessment before and after transurethral resection of the prostate in patients with lower urinary tract symptoms. ", 2001, World J Urol, Vol. 19, no. 5, pg. 358-64
  56. Quek KF, Low WY, Razack AH, Loh CS , "Psychological effects of treatment for lower urinary tract symptoms. ", 2000, BJU Int, Vol. 86, no. 6, pg. 630-3
  57. Moosa F, Abdullah BJJ, Kumar G, Razack A, Loh CS , "MR urography in the assessment of renal tract obstruction" Asia Oceania Journal of Radiology 1999, Vol. 3, no. 3
Article in Proceeding
  1. Ong TA, Lee PY, Ng CJ, Lee YK, Abdullah KL, Cheong AT, Abdul Razack AH. Impact and needs of prostate cancer survivors in a country with low incidence of prostate cancer. BJU Int. 2015. 116(Supp 1), pg 6.
  2. Cheong AT, Lee PY, Ng CJ, Khatijah LA, Lee YK, Ong TA, Azad HA Razack. 2014. PP026 Doctors' approach to decision support in counselling patients with prostate cancer. Malaysian Family Physician, Volume 9 Supplement 1: 44.
  3. Chirk Jenn Ng, Ping Yein Lee, Ai Theng Cheong, Yew Kong Lee, Teng Aik Ong, Azah Hassan Razack. 2014. Factors influencing decision-making in men with early prostate cancer: Malaysian healthcare professionals' perspectives. Malaysian Family Physician, Volume 9 Supplement 1: 45.
  4. Yew Kong Lee, Ping Yein Lee, Ai Theng Cheong, Chirk Jenn Ng, Khatijah Lim Abdullah, Teng Aik Ong, & Azad Hassan bin Abdul Razack. 2014. P2-12 Who Makes The Decision? Malaysian Health Care Professionals Views On Prostate Cancer Treatment. Med Decis Making 2014 34: E34.
Other Publications
  1. NY Yap, KL Ng, TA Ong, J Pailoor, AHA Razack, G Gobe, C Morais and R Rajandram. 2014. Clinical data as prognostic tools in the management of renal cell carcinoma (RCC). BJU International volume 113, Supplement 4 : 51 137 - Extended Abstract
  2. R Rajandram, NY Yap, J Pailoor, AHA Razack, KL NG, C Morais and G Gobe. 2014. Investigation of tumour necrosis factor receptor-associated factor 1 expression in renal cell carcinoma from a single asian centre. BJU International volume 113, Supplement 4 : 51-137 - Extended Abstract
  3. NY Yap, R Rajandram, J Pailoor, AHA Razack, TA Ong, KL Ng, C Morais and G Gobe. 2013. Evaluating the characteristics of newly diagnosed Renal Cell Carcinoma to improve patient outcome. 18 (suppl. 1):34. - Extended Abstract
  4. Rajandram R, NY Yap, J Pailoor, AHA Razack, KL NG, G Gobe C Morais (2013). Molecular Characteristics of Renal Cell Carcinoma- a study using TRAF1 and Malaysian patient cohort. Nephrology 18(suppl 1.) p47 - Extended Abstract

RESEARCH INTEREST


  • BCG and Bladder Cancer
  • Prostate cancer - proteomic and genomics

RESEARCH PROJECT


National
  1. 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG)
    Caspase-8 and TRAF1 as biomarkers of progression of Renal Cell Carcinomas ( Consultant)
  2. 2011 - 2012, Geran Penyelidikan Universiti Malaya (UMRG)
    Caspase-8 and TRAF1 as biomarkers of progression of Renal Cell Carcinomas ( Consultant)
  3. 2007 - 2009
    PSA and prostate cancer ( PROJECT LEADER)
  4. 2008 - 2009, Short Term Research Fund (Vote F)(PJP)
    Testosterone replacement in management of erectile dysfunction ( Principal Investigator(PI))
International
  1. 2015 - 2020, International Funding
    A multi-centre, prospective, longitudinal registry of patients with prostate cancer in Asia ( Principal Investigator(PI))
  2. 2016 - 2019, International Funding
    A Phase I V Interventional Safety, Efficacy and Quality of Life Study of ELIGARD in Prostate Cancer Patients in Asia (ELIGANT) ( Principal Investigator(PI))
  3. 2017 - 2018, International Funding
    The use o f fully interactive digital human anatomy atlas in teaching anatomy - pilot study ( Principal Investigator(PI))
  4. 2018 - 2018, International Funding
    Robotic-a ssisted percutaneous access Interventional, non-randomized, open-label, non-comparative and First-in-Man Study ( Principal Investigator(PI))

PAPER PRESENTED


INVITED SPEAKER
  1. Does Confusion Continue to Surround Catheter Care, 38th Congress of SIU, SIU (International) (04 Oct 2018 - 07 Oct 2018)

SUPERVISION


Postgraduate Student
PhD/ Doctoral
  1. (2011) STUDY ON THE ROLE OF CYP450 GENE POLYMORPHISMS, FREQUENCY OF TMPRSS2/ERG FUSION AND THEIR ASSOCIATIONS WITH HORMONAL AND IGF PROFILES IN THE RISK OF PROSTATE CANCER DEVELOPMENT IN MULTIETHNIC MALAYSIAN AND WESTERN POPULATIONS., Shanggar A/L Kuppusamy
  2. (2010) Application Of Lectin In The Study Of Prostate Cancer, JAIME JACQUELINE A/P JAYAPALAN
  3. (1997) Quality of Life Assessment in Patients With Lower Urinary Tract Symptoms, Quek Kia Fatt (University of Malaya (UM))
Master
  1. (2015) Repeat TRUS guided prostate biopsy: Does it provide any clinical benefit in patients with PSA level of 4-10ng/ml, Raymond Yii Shi Liang
  2. (2010) Ethnic variation in genetics and prostate cancer, Prevathe A/P Ponniah
  3. (2008) Factors affecting changes in serum sodium, pottasium, and osmolality in patients undergoing transurethral procedures., Kok Meng Sum
  4. (2005) SEXTANT VS VOLUME BASED EXTENDED TRUS PROSTATE BIOPSY - AN EXPERIENCE IN UMMC, YEAP CHEE LOONG
  5. (2004) CAUSES AND SIGNIFICANCE OF HAEMATURIA IN ADULTS IN UMMC, NG KIM Lim
  6. (1998) Review of Percutaneus Nephrolithotomy (PCNL) performed in UMMC, Alizan Mohd Khalil
  7. (1997) REVIEW OF RENAL CANCERS IN UMMC, THI HA HTUN
  8. (1997) REVIEW OF BLADDER CANCER IN UMMC, MUHAMMAD AFZAL